Many in the industry might welcome the flexibility that led to positive outcomes for oral contraceptives. Still, it might be worth objectively assessing the factors contributing to the outcome.
Take the right learning from a situation that was mostly about ministerial intervention
February 28, 2025 Latest NewsBioPharmaComment
Latest Video
New Stories
-
The 'Dispatched' Week in Review Podcast - 1 August
August 1, 2025 - - Podcast -
Trump administration takes another step in 'Most Favored Nation' push
August 1, 2025 - - Latest News -
Novartis backs the launch of a new cardiovascular disease program
August 1, 2025 - - Latest News -
Study reveals growing benefit of Lilly therapy for early symptomatic Alzheimer’s disease
August 1, 2025 - - Latest News -
New pharmacy-focused partnership marks the launch of two first-to-market biosimilars
August 1, 2025 - - Latest News -
Arrotex expands haematology-oncology portfolio through Antengene partnership
August 1, 2025 - - Latest News -
AbbVie therapy now available on the PBS for treatment of advanced Parkinson’s
August 1, 2025 - - Latest News